Yongan Pharmaceutical: Abnormal fluctuations in stock trading, there are no undisclosed matters that should be disclosed.

Yong'an Pharmaceutical announced that the company's stock price had deviated by more than 20% for two consecutive trading days on July 15th and 16th, 2026, which was considered abnormal volatility. After verification, it was found that there was no need to correct or supplement the information disclosed by the company in the previous period, and no undisclosed significant information was reported by the media. The company's operations, both internally and externally, were normal. There were no significant undisclosed matters for the company, controlling shareholder, or ultimate controller. During the period of abnormal volatility, the controlling shareholder and ultimate controller did not engage in any trading of the company's stock. The company reminds investors to invest rationally and be cautious of risks.